switch from tirzepatide to semaglutide Semaglutide: Safety Guide – PlexusDx Switching from tirzepatide to semaglutide:

This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA "Compounding and the FDA: Questions and Answers".) Clinical trial efficacy data (such as 14.9% mean weight loss in the STEP 1 trial for semaglutide and 22.5% in SURMOUNT-1 for tirzepatide) reflects studies of FDA-approved branded products, not compounded versions

This is the most common source of measurement error, and getting it wrong by even a few units changes your dose by a meaningful amount

It helps more than you would think

Muscle carnitine was evaluated in 2 studies (Rudman et al., 1977